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Introduction

The Placenta

Procedure

Preeclampsia is a life-threatening, pregnancy-associated disorder characterized by
the rapid development of hypertension with renal dysfunction. While preeclampsia
generally occurs later in pregnancy, early-onset preeclampsia (EOPE) can occur
much earlier and is usually more devastating. Early-onset preeclampsia is also
associated with an increased risk of maternal cardiovascular and metabolic disease
in mothers later in life and neurocognitive dysfunction in their offspring. EOPE is
strongly associated with abnormal placental development and fetal growth
restriction during pregnancy.

The placenta is a maternofetal organ that is essential to the survival of a
developing fetus. The placenta is composed of maternal tissue derived
from the endometrium and fetal tissue from the chorionic sac. Functions of
the placenta include facilitating blood flow, gas and nutrient exchange,
waste elimination, hormone production and regulating the body
temperature of the fetus. The placenta is also an immunoprivileged
organ—when exposed to antigens, there is no inflammatory response.
Maternal blood and fetal blood do not come in contact through the
placenta.

Pregnant women at Miami Valley Hospital have been approached for participation in
the study. Inclusion criteria include 1) age (18-40 years), 2) admission to labor and
delivery, 3) diagnosis of preeclampsia, and 4) singleton pregnancy. Women who are
obese or have diabetes have not been excluded but are noted to stratify the data.

Characteristics of
Preeclampsia

Preterm Birth

Low Birth
Weight

Sudden
Maternal
Hypertension

Defective
Spiral Artery
Remodeling

Transfer tissue to liquid nitrogen,
paraformaldehyde, and RNAlater.

Figure 1. The defining characteristics of preeclampsia, a pregnancy-associated disorder.
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Figure 2. Schematic of Hif-1α, hypoxia, and cell differentiation in the placenta.

Distinguish between the maternal and the fetal
tissue. Remove fetal membrane.
Collect samples from each quadrant of the fetal
and maternal aspects of the placenta.
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The placenta is a transient organ that is formed during pregnancy and is essential
for embryonic survival. Hypoxia-inducible factor 1 alpha (Hif-1α) is a critical oxygensensing transcription factor that has been implicated as a major regulator of
trophoblast differentiation. Trophoblasts are cells that make up the fetal component
of the placenta. Elevated Hif-1α has been linked to preeclampsia in humans. Our
findings, in a newly developed mouse model, provide compelling evidence that Hif1α is a critical molecular mediator of placental development and indicates that
prolonged expression of Hif-1α, exclusively in placental trophoblasts during
pregnancy, causes maternal pathology and fetal growth restriction that is
characteristic of EOPE. Although the association of Hif-1α and preeclampsia has
been suggested, no study has quantified the levels of Hif-1α in humans in EOPE
pregnancies. In addition, a comparison between early- and late-onset preeclampsia
has not been made. Our study will establish the relationship between Hif-1α-positive
placentas and the risk of future preeclamptic pregnancies as well as future maternal
health. This includes the prevalence of preeclampsia in a subsequent pregnancy,
long-term maternal cardiovascular health, and health issues in the offspring
including neurocognitive impairments. These findings will determine if Hif-1α is a
predictive marker for the risk of future adverse effects from preeclampsia in both
mothers and their offspring.

Upon delivery, a member of the team collects the placenta directly from the delivery
room and within 15 minutes collects tissue samples. 1 cm3 of tissue is collected
from four quadrants of each the fetal and maternal faces of the placenta.
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Analyze for Hif-1α using immunohistochemistry,
Western blot, and ELISA.
Figure 5. Schematic of collection process and four-quadrant system, fetal aspect up.
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This project will allow for us to determine the percentage of early onset preeclamptic
pregnancies which are Hif-1α positive. This information will then be applied to the
longitudinal portion of the study to allow for us to determine if Hif-1α can serve as a
marker of preeclampsia in a subsequent pregnancy. In addition, other data such as
preeclampsia with or without fetal growth restriction can be compared to the Hif-1α
positive or negative placentas to determine other clinical findings that may be
related to the presence of Hif-1α. We expect to answer are the following questions:
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Figure 4. Schematic of maternal and fetal arteries.

Risk Factors for Preeclampsia
Antiphospholipid syndrome
Prior preeclamptic pregnancy
Chronic hypertension
Pregestational diabetes
Multifetal pregnancy
Obesity (BMI >30)
In vitro fertilization (ART)
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Chronic kidney disease
Advanced maternal age (>40)
Family history of preeclampsia
First pregnancy
Age
Systemic lupus erythematosus
Prior pregnancy with IUGR

What is the prevalence of Hif-1α-positive EOPE pregnancies?
Is Hif-1α a predictive marker of EOPE in subsequent pregnancies?

Impact
If it is found that Hif-1α is a predictive marker of EOPE, women who are diagnosed
with EOPE will could have their placentas tested for Hif-1α to determine the risk of
EOPE in a subsequent pregnancy. In addition, this study will develop a longitudinal
relationship between Hif-1α to subsequent pregnancies in the mother and their
offspring.
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